Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferon-induced genes
- PMID: 21600883
- DOI: 10.1016/j.bbrc.2011.04.136
Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferon-induced genes
Abstract
Osteoblasts are rich in interferon-inducible transmembrane protein 5 (IFITM5), the expression of which peaks around the early mineralization stage. This membrane protein directly associates with FK506 binding protein 11 (FKBP11). To examine the molecular function of IFITM5, we analyzed the protein interaction network around IFITM5-FKBP11. We found that FKBP11 was associated with CD81, which interacts with prostaglandin F2 receptor negative regulator (FPRP) and CD9; cumulatively, these associations result in the formation of a FKBP11-CD81-[FPRP/CD9] complex. However, CD9 dissociated from the complex following expression of Ifitm5, which also led to osteoblast-specific increased expression of 5 interferon-induced genes: bone marrow stromal cell antigen 2 (Bst2), interferon inducible protein 1 (Irgm), interferon-induced protein with tetratricopeptide repeats 3 (Ifit3), b(2)-microglobulin (B2m), and MHC (A.CA/J(H-2K-f) class I antigen gene. Induction of these genes likely resulted from dissociation of CD9 from the FKBP11-CD81-[FPRP/CD9] complex. Cumulatively, these results suggest that IFITM5 is involved not only in bone formation, but also in immune system activity.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Role of S-palmitoylation on IFITM5 for the interaction with FKBP11 in osteoblast cells.PLoS One. 2013 Sep 18;8(9):e75831. doi: 10.1371/journal.pone.0075831. eCollection 2013. PLoS One. 2013. PMID: 24058703 Free PMC article.
-
Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice.J Bone Miner Metab. 2011 May;29(3):279-90. doi: 10.1007/s00774-010-0221-0. Epub 2010 Sep 14. J Bone Miner Metab. 2011. PMID: 20838829
-
FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein.J Biol Chem. 2001 Feb 16;276(7):4853-62. doi: 10.1074/jbc.M009859200. Epub 2000 Nov 21. J Biol Chem. 2001. PMID: 11087758
-
CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins.Eur J Immunol. 1996 Nov;26(11):2657-65. doi: 10.1002/eji.1830261117. Eur J Immunol. 1996. PMID: 8921952
-
The small interferon-induced transmembrane genes and proteins.J Interferon Cytokine Res. 2011 Jan;31(1):183-97. doi: 10.1089/jir.2010.0112. Epub 2010 Dec 19. J Interferon Cytokine Res. 2011. PMID: 21166591 Review.
Cited by
-
IFITM5 mutations and osteogenesis imperfecta.J Bone Miner Metab. 2016 Mar;34(2):123-31. doi: 10.1007/s00774-015-0667-1. Epub 2015 Jun 2. J Bone Miner Metab. 2016. PMID: 26031935 Review.
-
FK506-Binding Protein 11 Is a Novel Plasma Cell-Specific Antibody Folding Catalyst with Increased Expression in Idiopathic Pulmonary Fibrosis.Cells. 2022 Apr 14;11(8):1341. doi: 10.3390/cells11081341. Cells. 2022. PMID: 35456020 Free PMC article.
-
Osteogenesis imperfecta.Lancet. 2016 Apr 16;387(10028):1657-71. doi: 10.1016/S0140-6736(15)00728-X. Epub 2015 Nov 3. Lancet. 2016. PMID: 26542481 Free PMC article. Review.
-
Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation.J Bone Miner Res. 2013 Jul;28(7):1523-30. doi: 10.1002/jbmr.1891. J Bone Miner Res. 2013. PMID: 23408678 Free PMC article. Clinical Trial.
-
The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect.J Clin Invest. 2024 Jun 17;134(15):e170369. doi: 10.1172/JCI170369. J Clin Invest. 2024. PMID: 38885336 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
